Suzuki, Kazuhito https://orcid.org/0000-0002-0300-378X
Nishiwaki, Kaichi
Nagao, Riku
Katori, Mitsuji
Fukushima, Ryoko
Hattori, Daiki
Masuoka, Hidekazu
Yano, Shingo
Article History
Received: 26 May 2021
Revised: 29 July 2021
Accepted: 29 July 2021
First Online: 2 August 2021
Declarations
:
: K. Suzuki received personal fees from Takeda Pharmaceutical Company, Janssen Pharmaceutical K.K., Celgene, outside the submitted work; K. Nishiwaki reports personal fees from Kyowa Hakko Kirin Co, Ltd, outside the submitted work; Dr. Yano reports grants from Kyowa Kirin, grants from Astella Pharma, grants from Chugai Pharama, grants from Mochida Pharama, grants from Lilly Phrama, grants from Takeda Pharama, grants from MDS Pharama, grants from Pfizer, grants from Dai Nippon Sumitomo Pharama, grants from Ono Pharma, outside the submitted work; the other authors declare that they have no conflict of interest.